International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
Molecular Psychiatry September 7, 2022 Rebecca B Price, Nicholas Kissel, Andrew Baumeister et al. 80 citations
Abstract Depression is disabling and highly prevalent. Intravenous (IV) ketamine displays rapid-onset antidepressant properties, but little is known regarding which patients are most likely to benefit, limiting personalized prescriptions. We identified randomized controlled trials of IV ketamine that recruited individuals with a relevant psychiatric diagnosis (e.g., unipolar or bipolar...
DOI: 10.1038/s41380-022-01757-7 (opens in new tab)
Full text (opens in new tab)
Treatment-resistant depression
Depression treatment
Ketamine therapy
Mental health research
+1